Biofrontera Inc. has issued a supplement to its Proxy Statement for the upcoming 2025 Annual Meeting of Stockholders, scheduled for June 12, 2025. The company is urging shareholders to exercise their voting rights, highlighting the importance of their participation. Notably, the New York Stock Exchange has classified Proposal Nos. 2 and 3 as "routine" matters, allowing banks, brokers, and other nominees to vote on these proposals without direct instructions from shareholders. Proposal No. 2 involves amending the company's certificate of incorporation to increase authorized shares, and Proposal No. 3 pertains to the potential adjournment of the meeting to gather more votes if necessary. Biofrontera emphasizes that shareholders should provide voting instructions to ensure their preferences are reflected, particularly if their brokerage firms have opted not to vote on routine matters without direct guidance.